Apply for Funding

CPRIT offers several funding opportunities for promising cancer research, product development, and prevention programs. All funding opportunities are announced through formal Requests for Applications (RFAs) and applications must be submitted through the online application receipt system.

Learn more about the grants process.

Recruitment of Established Investigators

Instructions for Applicants

Program Academic Research
RFA Status Open
Description

Recruits outstanding senior research faculty with distinguished professional careers and established cancer research programs to academic institutions in Texas.

Award: Up to $6 million over a period of five years.

Review Cycle Fiscal Year 2022 - Cycle 1
RFA Release June 22, 2021
Application Receipt June 22, 2021 - June 20, 2022
Application Review Continuous
Award Notification Continuous

Recruitment of First-Time, Tenure-Track Faculty Members

Instructions for Applicants

Program Academic Research
RFA Status Open
Description

Supports very promising emerging investigators, pursuing their first faculty appointment in Texas, who have the ability to make outstanding contributions to the field of cancer research.

Award: Up to $2 million up to a period of five years.

Review Cycle Fiscal Year 2022 - Cycle 1
RFA Release June 22, 2021
Application Receipt June 22, 2021 - June 20, 2022
Application Review Continuous
Award Notification Continuous

Recruitment of Rising Stars

Instructions for Applicants

Program Academic Research
RFA Status Open
Description

Recruits outstanding early-stage investigators to Texas, who have demonstrated the promise for continued and enhanced contributions to the field of cancer research.

Award: Up to $4 million over a period of five years.

Review Cycle Fiscal Year 2022 - Cycle 1
RFA Release June 22, 2021
Application Receipt June 22, 2021 - June 20, 2022
Application Review Continuous
Award Notification Continuous

Company Relocation Product Development Awards

Instructions for Applicants

Program Product Development Research
RFA Status Open
Description

This award mechanism seeks to support early stage “startup” and established companies in the development of innovative products and services with significant potential impact on cancer patient care. The proposed project must further the development of new products or services for the diagnosis, treatment, or prevention of cancer; must foster a robust biotechnology industry ecosystem; or must fulfill a critical unmet need in cancer patient care. Companies must relocate to Texas upon receipt of award.

Read More

Review Cycle Fiscal Year 2022 - Cycle 1
RFA Release May 27, 2021
Application Receipt June 24, 2021 - August 04, 2021
Application Review October 2021
Award Notification February 2022

Seed Awards for Product Development Research

Instructions for Applicants

Program Product Development Research
RFA Status Open
Description

This award mechanism seeks to support early-stage "startup" companies in the development of innovative products, services, and infrastructure with significant potential impact on cancer patient care.

The proposed project must further the development of new products for the diagnosis, treatment, or prevention of cancer; must establish infrastructure that is critical to the development of a robust cancer biotech industry; or must fill a treatment or research gap. Company applicants must be headquartered in Texas or be willing to relocate to Texas upon receipt of award.

Read More

Review Cycle Fiscal Year 2022 - Cycle 1
RFA Release May 27, 2021
Application Receipt June 24, 2021 - August 04, 2021
Application Review October 2021
Award Notification February 2022

Texas Company Product Development Awards

Instructions for Applicants

Program Product Development Research
RFA Status Open
Description

This award mechanism seeks to support early-stage "startup" and established companies in the development of innovative products, services, and infrastructure with significant potential impact on cancer patient care.

The proposed project must further the development of new products for the diagnosis, treatment, or prevention of cancer; must establish infrastructure that is critical to the development of a robust cancer biotech industry; or must fill a treatment or research gap. Companies must be headquartered in Texas.

Read More

Review Cycle Fiscal Year 2022 - Cycle 1
RFA Release May 27, 2021
Application Receipt June 24, 2021 - August 04, 2021
Application Review October 2021
Award Notification February 2022

Evidence-Based Cancer Prevention Services

Program Prevention
RFA Status Open
Description

This award mechanism seeks to fund projects that will deliver evidence-based cancer prevention and control clinical services. Priority will be given to projects that propose to address CPRIT areas of emphasis and serve areas of the state not well addressed by current CPRIT funded projects. Only proposals for new projects are eligible under this mechanism. Eligible applications must include the delivery of services to nonmetropolitan (rural) and medically underserved counties in the state.

Award: Maximum of $1M; Maximum duration of 36 months.

A webinar will be held on June 16, 2021 regarding this RFA. Register Now!

Review Cycle Fiscal Year 2022 - Cycle 1
RFA Release May 07, 2021
Application Receipt June 03, 2021 - September 01, 2021
Application Review September 2021 - January 2022
Award Notification February 2022

Expansion of Cancer Prevention Services to Rural and Medically Underserved Populations

Program Prevention
RFA Status Open
Description

This award mechanism seeks to support the coordination and expansion of evidence based services to prevent cancer in underserved populations who do not have adequate access to cancer prevention interventions and health care, bringing together networks of public health and community partners to carry out programs tailored for their communities. Projects should identify cancers that cause the most burden in the community and use evidence-based models shown to work in similar communities to prevent and control these cancers. For the first expansion application, eligible applicants should propose to expand their programs to include additional types of prevention clinical services and/or an expansion of current clinical services into additional counties. For a subsequent expansion, additional clinical services and/or expansion to additional counties is optional; the number of clinical services delivered must be increased substantially if no further geographic or clinical service expansion is proposed.

Initial Expansion: up to $2M over 36 months

Maintenance Expansion: up to $2.5M over 60 months

A webinar will be held on June 16, 2021 regarding this RFA. Register Now!

Review Cycle Fiscal Year 2022 - Cycle 1
RFA Release May 07, 2021
Application Receipt June 03, 2021 - September 01, 2021
Application Review September 2021 - January 2022
Award Notification February 2022

Prevention Program Assessment

Program Prevention
RFA Status Open
Description

This award mechanism solicits applications for one project to assess the initial progress of the CPRIT Prevention Program since 2010 and to develop an assessment plan for the next stage of the CPRIT Prevention Program. The evaluation will use a mixed-methods approach, which combines quantitative and qualitative data to provide evidence of effectiveness and information about how CPRIT-related changes are embedded and sustained in organizations and populations. Evaluation findings will be used to improve program effectiveness and to inform decisions about future program development.

Award: Maximum of $750,000; Maximum duration of 24 months.

A webinar will be held on June 18, 2021 regarding this RFA. Register Now!

Review Cycle Fiscal Year 2022 - Cycle 1
RFA Release May 07, 2021
Application Receipt June 03, 2021 - September 01, 2021
Application Review September 2021 - January 2022
Award Notification February 2022

Tobacco Control and Lung Cancer Screening

Program Prevention
RFA Status Open
Description

This award mechanism seeks to fund programs on tobacco prevention and cessation, as well as screening for early detection of lung cancer. Through release of this RFA, CPRIT’s goal is to stimulate more programs across the state, thereby providing greater access for underserved populations and reducing the incidence and mortality rates of tobacco-related cancers. This RFA seeks to promote and deliver evidence-based programming designed to significantly increase tobacco cessation among adults and/or prevent tobacco use by youth.

Award: Maximum of $1 M; Maximum duration of 36 months

A webinar will be held on June 16, 2021 regarding this RFA. Register Now!

Review Cycle Fiscal Year 2022 - Cycle 1
RFA Release May 07, 2021
Application Receipt June 03, 2021 - September 01, 2021
Application Review September 2021 - January 2022
Award Notification February 2022